285 related articles for article (PubMed ID: 30413387)
1. Hepatocellular carcinoma in acute hepatic porphyrias: A Damocles Sword.
Peoc'h K; Manceau H; Karim Z; Wahlin S; Gouya L; Puy H; Deybach JC
Mol Genet Metab; 2019 Nov; 128(3):236-241. PubMed ID: 30413387
[TBL] [Abstract][Full Text] [Related]
2. Risk of primary liver cancer in acute hepatic porphyria patients: A matched cohort study of 1244 individuals.
Lissing M; Vassiliou D; Floderus Y; Harper P; Bottai M; Kotopouli M; Hagström H; Sardh E; Wahlin S
J Intern Med; 2022 Jun; 291(6):824-836. PubMed ID: 35112415
[TBL] [Abstract][Full Text] [Related]
3. AGA Clinical Practice Update on Diagnosis and Management of Acute Hepatic Porphyrias: Expert Review.
Wang B; Bonkovsky HL; Lim JK; Balwani M
Gastroenterology; 2023 Mar; 164(3):484-491. PubMed ID: 36642627
[TBL] [Abstract][Full Text] [Related]
4. Pathogenesis and clinical features of the acute hepatic porphyrias (AHPs).
Bonkovsky HL; Dixon N; Rudnick S
Mol Genet Metab; 2019 Nov; 128(3):213-218. PubMed ID: 30987916
[TBL] [Abstract][Full Text] [Related]
5. Acute hepatic porphyria and cancer risk: a nationwide cohort study.
Baravelli CM; Sandberg S; Aarsand AK; Nilsen RM; Tollånes MC
J Intern Med; 2017 Sep; 282(3):229-240. PubMed ID: 28730628
[TBL] [Abstract][Full Text] [Related]
6. The incidence of inherited porphyrias in Europe.
Elder G; Harper P; Badminton M; Sandberg S; Deybach JC
J Inherit Metab Dis; 2013 Sep; 36(5):849-57. PubMed ID: 23114748
[TBL] [Abstract][Full Text] [Related]
7. Human hereditary hepatic porphyrias.
Nordmann Y; Puy H
Clin Chim Acta; 2002 Nov; 325(1-2):17-37. PubMed ID: 12367763
[TBL] [Abstract][Full Text] [Related]
8. Hepatocellular carcinoma in patients with acute hepatic porphyria: frequency of occurrence and related factors.
Andant C; Puy H; Bogard C; Faivre J; Soulé JC; Nordmann Y; Deybach JC
J Hepatol; 2000 Jun; 32(6):933-9. PubMed ID: 10898313
[TBL] [Abstract][Full Text] [Related]
9. Hepatocellular Carcinoma in Acute Hepatic Porphyrias: Results from the Longitudinal Study of the U.S. Porphyrias Consortium.
Saberi B; Naik H; Overbey JR; Erwin AL; Anderson KE; Bissell DM; Bonkovsky HL; Phillips JD; Wang B; K Singal A; M McGuire B; Desnick RJ; Balwani M
Hepatology; 2021 May; 73(5):1736-1746. PubMed ID: 32681675
[TBL] [Abstract][Full Text] [Related]
10. Recent advances on porphyria genetics: Inheritance, penetrance & molecular heterogeneity, including new modifying/causative genes.
Yasuda M; Chen B; Desnick RJ
Mol Genet Metab; 2019 Nov; 128(3):320-331. PubMed ID: 30594473
[TBL] [Abstract][Full Text] [Related]
11. Heme biosynthesis and the porphyrias.
Phillips JD
Mol Genet Metab; 2019 Nov; 128(3):164-177. PubMed ID: 31326287
[TBL] [Abstract][Full Text] [Related]
12. High risk of primary liver cancer in a cohort of 179 patients with Acute Hepatic Porphyria.
Sardh E; Wahlin S; Björnstedt M; Harper P; Andersson DE
J Inherit Metab Dis; 2013 Nov; 36(6):1063-71. PubMed ID: 23344888
[TBL] [Abstract][Full Text] [Related]
13. Clinical features of acute attacks, chronic symptoms, and long-term complications among patients with acute hepatic porphyria in Japan: a real-world claims database study.
Horie Y; Yasuoka Y; Adachi T
Orphanet J Rare Dis; 2023 Dec; 18(1):384. PubMed ID: 38066651
[TBL] [Abstract][Full Text] [Related]
14. The acute hepatic porphyrias: current status and future challenges.
Siegesmund M; van Tuyll van Serooskerken AM; Poblete-Gutiérrez P; Frank J
Best Pract Res Clin Gastroenterol; 2010 Oct; 24(5):593-605. PubMed ID: 20955962
[TBL] [Abstract][Full Text] [Related]
15. Biallelic inactivation of protoporphyrinogen oxidase and hydroxymethylbilane synthase is associated with liver cancer in acute porphyrias.
Schneider-Yin X; van Tuyll van Serooskerken AM; Siegesmund M; Went P; Barman-Aksözen J; Bladergroen RS; Komminoth P; Cloots RH; Winnepenninckx VJ; zur Hausen A; Weber M; Driessen A; Poblete-Gutiérrez P; Bauer P; Schroeder C; van Geel M; Minder EI; Frank J
J Hepatol; 2015 Mar; 62(3):734-8. PubMed ID: 25445397
[TBL] [Abstract][Full Text] [Related]
16. [Porphyrias-what is verified?].
Stölzel U; Kubisch I; Stauch T
Internist (Berl); 2018 Dec; 59(12):1239-1248. PubMed ID: 30328490
[TBL] [Abstract][Full Text] [Related]
17. Expert consensus statement on acute hepatic porphyria in Belgium.
Gilles A; Vermeersch S; Vermeersch P; Wolff F; Cotton F; Tilleux S; Cassiman D
Acta Clin Belg; 2022 Aug; 77(4):735-741. PubMed ID: 34369323
[TBL] [Abstract][Full Text] [Related]
18. Acute porphyrias - A neurological perspective.
Gerischer LM; Scheibe F; Nümann A; Köhnlein M; Stölzel U; Meisel A
Brain Behav; 2021 Nov; 11(11):e2389. PubMed ID: 34661997
[TBL] [Abstract][Full Text] [Related]
19. RNAi therapy with givosiran significantly reduces attack rates in acute intermittent porphyria.
Sardh E; Harper P
J Intern Med; 2022 May; 291(5):593-610. PubMed ID: 35067977
[TBL] [Abstract][Full Text] [Related]
20. Risk for incident comorbidities, nonhepatic cancer and mortality in acute hepatic porphyria: A matched cohort study in 1244 individuals.
Lissing M; Vassiliou D; Floderus Y; Harper P; Yan J; Hagström H; Sardh E; Wahlin S
J Inherit Metab Dis; 2023 Mar; 46(2):286-299. PubMed ID: 36546345
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
